ETC-1002 Lowers LDL-Cholesterol and is Well Tolerated in Hypercholesterolemic Patients Across Four Phase 2a Studies by Newton, Roger S., PhD, Ballantyne, Christie M., MD, Thompson, Paul Davis, MD, MacDougall, Diane Elaine, MS, Hanselman, Jeffrey Christian, MS, Margulies, Janice Rose, MS, Synowiec, Richard F., MS, Johnson, James Roy, PhD, McBride, Scott James, MA, Rosenberg, Noah L., MD

Get full text